J. Christopher Love
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
J. Christopher Love has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Neil Chandra Dalvie
Department of Systems Biology, Harvard Medical School, Boston, USA
23 shared publications Kerry R. Love
Department of Chemical Engineering Massachusetts Institute of Technology Cambridge Massachusetts USA
17 shared publications- Alex K. Shalek
Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA
15 shared publications Christopher A. Naranjo
The Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Cambridge Massachusetts USA
15 shared publicationsTodd M. Gierahn
14 shared publications- Viktor A. Adalsteinsson
Broad Institute of MIT and Harvard, Cambridge, USA
14 shared publications
Latest Publications
- Open Access
Radiation therapy synergizes with mRNA vaccination to overcome microglia-mediated suppression of dendritic cell migration and T cell priming in glioblastoma
Glioblastomas (GBMs) are uniformly fatal brain tumors resistant to immunotherapy, yet the mechanisms driving immune dysfunction remain poorly understood. Here we identify a tissue-specific mechanism of dendritic cell (DC) dysfunction contributing to GBM immune evasion. We demonstrate that while systemic immunity depends on type 1 conventional DCs (cDC1s), GBMs preferentially accumulate cDC2s with impaired antigen-presenting capacity. Further, microglia-derived GAS6 and PROS1 signaling through the AXL receptor on DCs suppresses DC activation and, critically, migration to tumor-draining lymph nodes. Pharmacologic AXL inhibition enhances DC migration and consequently anti-tumor immunity. Importantly, radiation therapy activates cDC1-mediated endogenous immune responses, which synergizes with mRNA vaccination to promote complete and durable immune-mediated tumor regression. These findings establish DC-mediated immunity as a therapeutic target in brain tumors and reveal a synergistic mechanism for combining radiation with personalized cancer vaccines. Highlights: ● The GBM TME is dominated by cDC2 responses, with poor accumulation of cDC1s and blunted systemic antitumor immunity ● Microglia suppress cDC migration and activation in the CNS via AXL signaling, and AXL blockade restores DC activation and migration ● Radiation therapy reactivates cDC1-mediated endogenous immunity against GBM ● Radiation therapy and tumor antigen-targeting mRNA vaccination achieve durable tumor cures in orthotopic and autochthonous GBM models
Open AccessRadiation therapy synergizes with mRNA vaccination to overcome microglia-mediated suppression of dendritic cell migration and T cell priming in glioblastoma
Glioblastomas (GBMs) are uniformly fatal brain tumors resistant to immunotherapy, yet the mechanisms driving immune dysfunction remain poorly understood. Here we identify a tissue-specific mechanism of dendritic cell (DC) dysfunction contributing to GBM immune evasion. We demonstrate that while systemic immunity depends on type 1 conventional DCs (cDC1s), GBMs preferentially accumulate cDC2s with impaired antigen-presenting capacity. Further, microglia-derived GAS6 and PROS1 signaling through the AXL receptor on DCs suppresses DC activation and, critically, migration to tumor-draining lymph nodes. Pharmacologic AXL inhibition enhances DC migration and consequently anti-tumor immunity. Importantly, radiation therapy activates cDC1-mediated endogenous immune responses, which synergizes with mRNA vaccination to promote complete and durable immune-mediated tumor regression. These findings establish DC-mediated immunity as a therapeutic target in brain tumors and reveal a synergistic mechanism for combining radiation with personalized cancer vaccines. Highlights: ● The GBM TME is dominated by cDC2 responses, with poor accumulation of cDC1s and blunted systemic antitumor immunity ● Microglia suppress cDC migration and activation in the CNS via AXL signaling, and AXL blockade restores DC activation and migration ● Radiation therapy reactivates cDC1-mediated endogenous immunity against GBM ● Radiation therapy and tumor antigen-targeting mRNA vaccination achieve durable tumor cures in orthotopic and autochthonous GBM models
- Open Access
Modeling lung adenocarcinoma using layer-by-layer nanoparticles mitigates innate immune cell activation
Lung adenocarcinoma, driven frequently by KRAS and p53 mutations, remains a leading cause of cancer mortality. Current state-of-the-art genetically engineered mouse models often rely on viral delivery of recombinases, such as Cre recombinase, to initiate transformation. However, viral particles can infect and activate innate immune cells, thus potentially impacting studies of tumor-immune dynamics. Here, we develop a layer-by-layer (LbL) polyplex platform using poly(β-aminoester) (PBAE) polymers layered with poly-L-aspartic acid (PLD) to deliver Cre mRNA to lungs while avoiding immune cell transfection and activation. PLD-coated nanoparticles (PLD-NPs) exhibit stable mRNA encapsulation and efficient transfection in vitro, even after lyophilization and long-term storage. In Kras LSL-G12D/+ ;p53 flox/flox (KP) mice, PLD-NPs initiate lung adenocarcinomas that mirror human histopathology without infecting or activating dendritic cells and alveolar macrophages, unlike lentiviral (LV) or adenoviral delivery methods. Single-cell transcriptional profiling revealed that LV administration drives long-term upregulation of antigen presentation and costimulatory machinery in lung-resident myeloid populations. This persistent immune activation is avoided by NP delivery. By uncoupling tumor initiation from innate immune activation, this platform enables the high-fidelity interrogation of tumor-immune dynamics, especially for non-inflammation-driven lung cancer.
Open AccessModeling lung adenocarcinoma using layer-by-layer nanoparticles mitigates innate immune cell activation
Lung adenocarcinoma, driven frequently by KRAS and p53 mutations, remains a leading cause of cancer mortality. Current state-of-the-art genetically engineered mouse models often rely on viral delivery of recombinases, such as Cre recombinase, to initiate transformation. However, viral particles can infect and activate innate immune cells, thus potentially impacting studies of tumor-immune dynamics. Here, we develop a layer-by-layer (LbL) polyplex platform using poly(β-aminoester) (PBAE) polymers layered with poly-L-aspartic acid (PLD) to deliver Cre mRNA to lungs while avoiding immune cell transfection and activation. PLD-coated nanoparticles (PLD-NPs) exhibit stable mRNA encapsulation and efficient transfection in vitro, even after lyophilization and long-term storage. In Kras LSL-G12D/+ ;p53 flox/flox (KP) mice, PLD-NPs initiate lung adenocarcinomas that mirror human histopathology without infecting or activating dendritic cells and alveolar macrophages, unlike lentiviral (LV) or adenoviral delivery methods. Single-cell transcriptional profiling revealed that LV administration drives long-term upregulation of antigen presentation and costimulatory machinery in lung-resident myeloid populations. This persistent immune activation is avoided by NP delivery. By uncoupling tumor initiation from innate immune activation, this platform enables the high-fidelity interrogation of tumor-immune dynamics, especially for non-inflammation-driven lung cancer.
- Open Access
- 11 May 2026
- Published by Springer Nature in Microbial Cell Factories
- Vol. 25 (1)
Deletion of low-essentiality, secretion-associated genes enhances recombinant protein production in Komagataella phaffii
Background: Komagataella phaffii (K. phaffii) is used to manufacture biologic medicines, food proteins, reagents, and materials. Despite its increasing prevalence, further improvements to its productivity would enhance its economic and operational benefits. Genomic engineering represents one approach to increase its cell-specific productivity. We hypothesized that combining the metrics for the relative essentiality of genes with biological inference for relevance to protein secretion could identify genes that, when disrupted, would improve specific productivity in the resulting strains. Results: The essentiality of genes in K. phaffii (NRRL Y-11430) were predicted through a genome-wide knockout screen using CRISPR-Cas9. Based on the results from this screen, we selected and subsequently disrupted the least essential genes from two gene groups heavily associated with secretion, namely those relating to the cell wall and vacuolar transport. Strains of K. phaffii with single gene disruptions from these gene sets showed significantly improved production of a monoclonal antibody (mAb). These strains exhibited no discernible differences in growth or apparent profiles of host cell proteins when compared to the parental strain. The best-performing strains consistently showed 2-3x enhancements in specific productivity and titers across scales (3–150 mL), culture formats (plates, flasks, bioreactors), and processing operations (batch and fed-batch). Conclusions: This study demonstrates how combining data on gene essentiality and prior knowledge of biological pathways related to a phenotypic trait of interest (here protein secretion) can inform strain engineering to enhance the trait. This study expands the catalog of genetically engineered strains of K. phaffii with improved productivity. These strains support the long-term goal of achieving low-cost, high-volume production of recombinant proteins using this host. Further engineering of these strains and optimization of fermentation processes could enable volumetric productivities comparable to those of other established hosts used to produce mAbs and other complex recombinant proteins.
- 11 May 2026
- Published by Springer Nature in Microbial Cell Factories
- Vol. 25 (1)
Open AccessDeletion of low-essentiality, secretion-associated genes enhances recombinant protein production in Komagataella phaffii
Background: Komagataella phaffii (K. phaffii) is used to manufacture biologic medicines, food proteins, reagents, and materials. Despite its increasing prevalence, further improvements to its productivity would enhance its economic and operational benefits. Genomic engineering represents one approach to increase its cell-specific productivity. We hypothesized that combining the metrics for the relative essentiality of genes with biological inference for relevance to protein secretion could identify genes that, when disrupted, would improve specific productivity in the resulting strains. Results: The essentiality of genes in K. phaffii (NRRL Y-11430) were predicted through a genome-wide knockout screen using CRISPR-Cas9. Based on the results from this screen, we selected and subsequently disrupted the least essential genes from two gene groups heavily associated with secretion, namely those relating to the cell wall and vacuolar transport. Strains of K. phaffii with single gene disruptions from these gene sets showed significantly improved production of a monoclonal antibody (mAb). These strains exhibited no discernible differences in growth or apparent profiles of host cell proteins when compared to the parental strain. The best-performing strains consistently showed 2-3x enhancements in specific productivity and titers across scales (3–150 mL), culture formats (plates, flasks, bioreactors), and processing operations (batch and fed-batch). Conclusions: This study demonstrates how combining data on gene essentiality and prior knowledge of biological pathways related to a phenotypic trait of interest (here protein secretion) can inform strain engineering to enhance the trait. This study expands the catalog of genetically engineered strains of K. phaffii with improved productivity. These strains support the long-term goal of achieving low-cost, high-volume production of recombinant proteins using this host. Further engineering of these strains and optimization of fermentation processes could enable volumetric productivities comparable to those of other established hosts used to produce mAbs and other complex recombinant proteins.
- Open Access
- 17 February 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (8)
Pichia-CLM: A language model–based codon optimization pipeline for Komagataella phaffii
The preference in synonymous codon usage—the so-called codon usage bias (CUB)—is governed by several factors such as the host organism, context and function of the gene, and the position of the codon within the gene itself. We demonstrated that this mapping can be learned from the host’s genome using language models and subsequently applied for codon optimization of heterologous proteins expressed by the host. This pipeline called Pichia–Codon language model (Pichia-CLM) was applied to the industrial host organism, Komagataella phaffii. With this approach, production of heterologous proteins was enhanced up to threefold compared to their native sequences. Furthermore, Pichia-CLM consistently yielded constructs with enhanced productivity for proteins of varied complexity, compared to commercially available tools. Finally, we showed that Pichia-CLM generates sequences resembling the properties of codon usage found in the host’s intrinsic host cell proteins and learned features such as avoiding negative cis-regulatory and repeat elements based on patterns in the genome data. These results show the potential of language models to unbiasedly learn patterns and design robust sequences for improved protein production.
- 17 February 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (8)
Open AccessPichia-CLM: A language model–based codon optimization pipeline for Komagataella phaffii
The preference in synonymous codon usage—the so-called codon usage bias (CUB)—is governed by several factors such as the host organism, context and function of the gene, and the position of the codon within the gene itself. We demonstrated that this mapping can be learned from the host’s genome using language models and subsequently applied for codon optimization of heterologous proteins expressed by the host. This pipeline called Pichia–Codon language model (Pichia-CLM) was applied to the industrial host organism, Komagataella phaffii. With this approach, production of heterologous proteins was enhanced up to threefold compared to their native sequences. Furthermore, Pichia-CLM consistently yielded constructs with enhanced productivity for proteins of varied complexity, compared to commercially available tools. Finally, we showed that Pichia-CLM generates sequences resembling the properties of codon usage found in the host’s intrinsic host cell proteins and learned features such as avoiding negative cis-regulatory and repeat elements based on patterns in the genome data. These results show the potential of language models to unbiasedly learn patterns and design robust sequences for improved protein production.
- Open Access
- 7 February 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (5) , 1405-1412
Gaussian Processes for Predictive QSAR Modeling of Chromatographic Processes
Chromatography is a key unit operation in the biopharmaceutical manufacturing process used for protein purification and polishing. Design and optimization of these processes are resource‐intensive resulting from the complex combinatorial design space. This constraint combined with the wide diversity in therapeutic formats and increased pressure for timely delivery to the market necessitates an efficient, fast, robust and generalized framework for process design and optimization. Here we present Gaussian processes as a potent machine learning methodology for predictive modeling in the context of QSAR modeling used for resin and solvent condition selection. We highlight the on‐par predictive power of Gaussian Processes with other reported machine learning algorithms. Furthermore, we demonstrate additional properties of Gaussian processes such as its ability to provide confidence estimates for its prediction that makes it suitable for model‐assisted optimization. Finally, we demonstrate the possibility to derive feature importances from Gaussian processes, making these models as interpretable as ensembled tree‐based methods such as random forests.
- 7 February 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (5) , 1405-1412
Open AccessGaussian Processes for Predictive QSAR Modeling of Chromatographic Processes
Chromatography is a key unit operation in the biopharmaceutical manufacturing process used for protein purification and polishing. Design and optimization of these processes are resource‐intensive resulting from the complex combinatorial design space. This constraint combined with the wide diversity in therapeutic formats and increased pressure for timely delivery to the market necessitates an efficient, fast, robust and generalized framework for process design and optimization. Here we present Gaussian processes as a potent machine learning methodology for predictive modeling in the context of QSAR modeling used for resin and solvent condition selection. We highlight the on‐par predictive power of Gaussian Processes with other reported machine learning algorithms. Furthermore, we demonstrate additional properties of Gaussian processes such as its ability to provide confidence estimates for its prediction that makes it suitable for model‐assisted optimization. Finally, we demonstrate the possibility to derive feature importances from Gaussian processes, making these models as interpretable as ensembled tree‐based methods such as random forests.
- Open Access
- 4 February 2026
- Published by Springer Nature in Microbial Cell Factories
- Vol. 25 (1)
Systematic perturbation of cultures of K. phaffii by carbon co-feeding show gene signatures associated with production of recombinant proteins
Background: Demand for recombinant proteins is rapidly growing, driven by their use as biotherapeutics, vaccine components, industrial enzymes, and food ingredients. The growing market requires novel strategies for increasing protein production in cellular hosts. Systems-level frameworks have been used to improve production, but have had difficulty relating complex cellular pathways with protein expression. Here, we demonstrate a method for mapping relationships between gene expression signatures and carbon source-related phenotypes related to recombinant protein production. Results: Our approach induces systematic perturbations in cultures of K. phaffii using varied co-feeds of carbon sources. The different carbon sources significantly impacted cell growth, specific productivity, and transcriptional states. With these data, we identified metagenes for both immunoglobulin G1 monoclonal antibody (IgG1) and Variable domain on a heavy chain (VHH) antibody that explained significant transcriptomic variance. These metagenes strongly associated with two phenotypes: production of recombinant protein-to-biomass ratio, and response to methanol induction. We used these results to identify and knockout 31 novel gene targets for which expression inversely correlated with productivity. Nine of these genes improved productivity of IgG1 by up to 3x and ten genes increased productivity of VHH by up to 1.7x. Many of these genes are involved in the modulation and progression of the cell cycle but interestingly, disruption had little to no impact on cell growth. Conclusion: This study establishes a framework for relating gene signatures to complex cellular phenotypes, providing a robust methodology for assessing production processes and identifying new targets for cellular engineering. While the identified specific metagenes depend on the complexity and structure of the recombinant protein produced, this framework is extensible across diverse proteins and potentially other host organisms. These signatures may serve as scale-independent, cellular-level metrics for traits like efficiency of production of recombinant proteins, facilitating the translation of findings across different scales and cultivation modes. Furthermore, this framework enables the identification of novel targets for genomic modifications that can improve strain performance, offering a predictive tool for the rational design of high-performing microbial cell factories.
- 4 February 2026
- Published by Springer Nature in Microbial Cell Factories
- Vol. 25 (1)
Open AccessSystematic perturbation of cultures of K. phaffii by carbon co-feeding show gene signatures associated with production of recombinant proteins
Background: Demand for recombinant proteins is rapidly growing, driven by their use as biotherapeutics, vaccine components, industrial enzymes, and food ingredients. The growing market requires novel strategies for increasing protein production in cellular hosts. Systems-level frameworks have been used to improve production, but have had difficulty relating complex cellular pathways with protein expression. Here, we demonstrate a method for mapping relationships between gene expression signatures and carbon source-related phenotypes related to recombinant protein production. Results: Our approach induces systematic perturbations in cultures of K. phaffii using varied co-feeds of carbon sources. The different carbon sources significantly impacted cell growth, specific productivity, and transcriptional states. With these data, we identified metagenes for both immunoglobulin G1 monoclonal antibody (IgG1) and Variable domain on a heavy chain (VHH) antibody that explained significant transcriptomic variance. These metagenes strongly associated with two phenotypes: production of recombinant protein-to-biomass ratio, and response to methanol induction. We used these results to identify and knockout 31 novel gene targets for which expression inversely correlated with productivity. Nine of these genes improved productivity of IgG1 by up to 3x and ten genes increased productivity of VHH by up to 1.7x. Many of these genes are involved in the modulation and progression of the cell cycle but interestingly, disruption had little to no impact on cell growth. Conclusion: This study establishes a framework for relating gene signatures to complex cellular phenotypes, providing a robust methodology for assessing production processes and identifying new targets for cellular engineering. While the identified specific metagenes depend on the complexity and structure of the recombinant protein produced, this framework is extensible across diverse proteins and potentially other host organisms. These signatures may serve as scale-independent, cellular-level metrics for traits like efficiency of production of recombinant proteins, facilitating the translation of findings across different scales and cultivation modes. Furthermore, this framework enables the identification of novel targets for genomic modifications that can improve strain performance, offering a predictive tool for the rational design of high-performing microbial cell factories.
- Open Access
Molecular determinants of antibody-mediated priming to enhance detection of ctDNA
Liquid biopsies can enable cancer detection and monitoring yet remain limited by low concentrations of ctDNA. To address this limitation, we previously introduced a monoclonal antibody (mAb) “priming agent” that transiently increased the concentration of ctDNA in blood. Here, we investigated the molecular features that drive this effect. In a panel of novel mAbs that bound cfDNA, both those targeting dsDNA and those targeting mononucleosomes increased the concentration of ctDNA. mAbs with high avidity to dsDNA performed best, suggesting dsDNA as the key binding target. One agent preserved short, biologically informative molecules of cfDNA typically depleted at baseline. The Fc domain was dispensable, as F(ab’)2 fragments retained priming activity. Leveraging these insights, we engineered single-chain agents using the dsDNA binding domain sso7d, expanding priming strategies beyond immunoglobulins. This study identifies the molecular features and general design principles for mAb-based priming agents to enhance recovery and detection of ctDNA. Significance: Low concentration of ctDNA limits the sensitivity of liquid biopsies in many applications. This study shows how engineered antibodies and other dsDNA-binding molecules can inhibit clearance of ctDNA from the bloodstream and increase concentration of ctDNA in a blood draw, and identifies the key features that enable this activity. Modulation of cfDNA in the bloodstream using these agents can increase recovery of ctDNA and improve the performance of liquid biopsies for cancer detection.
Open AccessMolecular determinants of antibody-mediated priming to enhance detection of ctDNA
Liquid biopsies can enable cancer detection and monitoring yet remain limited by low concentrations of ctDNA. To address this limitation, we previously introduced a monoclonal antibody (mAb) “priming agent” that transiently increased the concentration of ctDNA in blood. Here, we investigated the molecular features that drive this effect. In a panel of novel mAbs that bound cfDNA, both those targeting dsDNA and those targeting mononucleosomes increased the concentration of ctDNA. mAbs with high avidity to dsDNA performed best, suggesting dsDNA as the key binding target. One agent preserved short, biologically informative molecules of cfDNA typically depleted at baseline. The Fc domain was dispensable, as F(ab’)2 fragments retained priming activity. Leveraging these insights, we engineered single-chain agents using the dsDNA binding domain sso7d, expanding priming strategies beyond immunoglobulins. This study identifies the molecular features and general design principles for mAb-based priming agents to enhance recovery and detection of ctDNA. Significance: Low concentration of ctDNA limits the sensitivity of liquid biopsies in many applications. This study shows how engineered antibodies and other dsDNA-binding molecules can inhibit clearance of ctDNA from the bloodstream and increase concentration of ctDNA in a blood draw, and identifies the key features that enable this activity. Modulation of cfDNA in the bloodstream using these agents can increase recovery of ctDNA and improve the performance of liquid biopsies for cancer detection.
- Open Access
PD-1 blockade during T cell priming enhances long-term protection against metastatic tumors by epigenetically tuning T cell exhaustion
In cancer, CD8 + T cell responses are dominated by exhausted T cells, which can be reinvigorated using immune checkpoint blockade therapy and can control large tumors. However, it remains unclear which T cell fate best supports long-term immunity following tumor regression or clearance and a period of minimal antigen load. This question is particularly relevant following surgical tumor resection, when tuning the immune system could prevent recurrence. To determine which T cell fate provides durable protection following surgery and metastatic rechallenge, we modulated T cell priming using anti-PD-1, IFN-β or agonistic anti-CD40 and assessed effects on CD8 + T cell differentiation and overall survival. IFN-β and anti-CD40 promoted effector and memory-like T cell states, respectively, whereas anti-PD-1 did not markedly alter T cell differentiation, yet conferred the greatest survival benefit against metastatic tumors. Notably, anti-PD-1 induced epigenetic remodeling, which was detectable upon metastatic recall, consistent with the maintenance of a circulatory intermediate-exhausted T cell state. Thus, while effector and memory precursor-like T cells could be generated with IFN-β and agonistic anti-CD40, only the intermediate-exhausted T cell state driven by anti-PD-1 supported durable anti-tumor immunity. Summary: This study shows that PD-1 blockade during T cell priming promotes a circulatory intermediate-exhausted CD8⁺ T cell state that uniquely supports durable anti-tumor immunity after surgical resection and metastatic challenge, outperforming effector or memory-like T cell responses generated by IFN-β or CD40 agonist treatment, respectively.
Open AccessPD-1 blockade during T cell priming enhances long-term protection against metastatic tumors by epigenetically tuning T cell exhaustion
In cancer, CD8 + T cell responses are dominated by exhausted T cells, which can be reinvigorated using immune checkpoint blockade therapy and can control large tumors. However, it remains unclear which T cell fate best supports long-term immunity following tumor regression or clearance and a period of minimal antigen load. This question is particularly relevant following surgical tumor resection, when tuning the immune system could prevent recurrence. To determine which T cell fate provides durable protection following surgery and metastatic rechallenge, we modulated T cell priming using anti-PD-1, IFN-β or agonistic anti-CD40 and assessed effects on CD8 + T cell differentiation and overall survival. IFN-β and anti-CD40 promoted effector and memory-like T cell states, respectively, whereas anti-PD-1 did not markedly alter T cell differentiation, yet conferred the greatest survival benefit against metastatic tumors. Notably, anti-PD-1 induced epigenetic remodeling, which was detectable upon metastatic recall, consistent with the maintenance of a circulatory intermediate-exhausted T cell state. Thus, while effector and memory precursor-like T cells could be generated with IFN-β and agonistic anti-CD40, only the intermediate-exhausted T cell state driven by anti-PD-1 supported durable anti-tumor immunity. Summary: This study shows that PD-1 blockade during T cell priming promotes a circulatory intermediate-exhausted CD8⁺ T cell state that uniquely supports durable anti-tumor immunity after surgical resection and metastatic challenge, outperforming effector or memory-like T cell responses generated by IFN-β or CD40 agonist treatment, respectively.
- Open Access
GPR15 and CD38 define a subset of peripheral blood pathogenic effector Th2 cells associated with active eosinophilic esophagitis
Eosinophilic esophagitis (EoE) is a chronic allergic disease driven by exposure to culprit antigens. Due to the local nature of the inflammation, diagnosis and assessment are limited to invasive procedures. Based on prior single-cell RNA sequencing (scRNA-seq) data linking peripheral GPR15+ pathogenic effector Th2 (peTh2) cells to esophageal tissue peTh2s, we hypothesized the direct involvement of GPR15+ peTh2 cells in EoE pathogenesis and aimed to further evaluate their association with EoE disease status. We subjected samples from subjects with or without EoE to flow cytometry (n = 74 peripheral blood, 17 biopsy) and scRNA-seq (n = 27 peripheral blood, 10 biopsy). Expression of GPR15 by peripheral peTh2 cells was increased in EoE, and these cells expressed increased CD38 in active EoE--findings recapitulated in esophageal biopsies. We also identified a peTh2-associated, CD38-containing gene expression program that peripheral GPR15+ peTh2 cells upregulated in active EoE. The level of upregulation was distinct from other circulating peTh2 cells and was more similar to that seen in esophageal peTh2 cells. An association between expression of GPR15 by peripheral peTh2 cells, the aryl hydrocarbon receptor was strongest in subjects with EoE, suggesting an environmental exposure or susceptibility. The magnitude of GPR15 expression by peripheral peTh2 cells could effectively in discriminate active EoE from no EoE in our study population (AUC 0.93). Our data suggest that EoE-related peTh2 cells are identifiable and accessible in the peripheral blood, and could be exploited in both clinical practice as a non-invasive biomarker and continued investigation into mechanisms driving EoE. One sentence summary: GPR15 marks a subset of peripheral blood pathogenic effector Th2 cells associated with eosinophilic esophagitis (EoE) that upregulate CD38 during active disease – an observation that has potential to be used for non-invasive diagnosis and monitoring of EoE and that has suggests new mechanisms driving this increasingly prevalent allergic disease.
Open AccessGPR15 and CD38 define a subset of peripheral blood pathogenic effector Th2 cells associated with active eosinophilic esophagitis
Eosinophilic esophagitis (EoE) is a chronic allergic disease driven by exposure to culprit antigens. Due to the local nature of the inflammation, diagnosis and assessment are limited to invasive procedures. Based on prior single-cell RNA sequencing (scRNA-seq) data linking peripheral GPR15+ pathogenic effector Th2 (peTh2) cells to esophageal tissue peTh2s, we hypothesized the direct involvement of GPR15+ peTh2 cells in EoE pathogenesis and aimed to further evaluate their association with EoE disease status. We subjected samples from subjects with or without EoE to flow cytometry (n = 74 peripheral blood, 17 biopsy) and scRNA-seq (n = 27 peripheral blood, 10 biopsy). Expression of GPR15 by peripheral peTh2 cells was increased in EoE, and these cells expressed increased CD38 in active EoE--findings recapitulated in esophageal biopsies. We also identified a peTh2-associated, CD38-containing gene expression program that peripheral GPR15+ peTh2 cells upregulated in active EoE. The level of upregulation was distinct from other circulating peTh2 cells and was more similar to that seen in esophageal peTh2 cells. An association between expression of GPR15 by peripheral peTh2 cells, the aryl hydrocarbon receptor was strongest in subjects with EoE, suggesting an environmental exposure or susceptibility. The magnitude of GPR15 expression by peripheral peTh2 cells could effectively in discriminate active EoE from no EoE in our study population (AUC 0.93). Our data suggest that EoE-related peTh2 cells are identifiable and accessible in the peripheral blood, and could be exploited in both clinical practice as a non-invasive biomarker and continued investigation into mechanisms driving EoE. One sentence summary: GPR15 marks a subset of peripheral blood pathogenic effector Th2 cells associated with eosinophilic esophagitis (EoE) that upregulate CD38 during active disease – an observation that has potential to be used for non-invasive diagnosis and monitoring of EoE and that has suggests new mechanisms driving this increasingly prevalent allergic disease.
- Top Cited PapersOpen Access
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Accelerating cell culture media development using Bayesian optimization-based iterative experimental design
Optimizing operational conditions for complex biological systems used in life sciences research and biotechnology is an arduous task. Here, we apply a Bayesian Optimization-based iterative framework for experimental design to accelerate cell culture media development for two applications. First, we show that this approach yields new compositions of media with cytokine supplementation to maintain the viability and distribution of human peripheral blood mononuclear cells in the culture. Second, we apply this framework to optimize the production of three recombinant proteins in cultivations of K.phaffii. We identified conditions with improved outcomes for both applications compared to the initial standard media using 3–30 times fewer experiments than that estimated for other methods such as the standard Design of Experiments. Subsequently, we also demonstrated the extensibility of our approach to efficiently account for additional design factors through transfer learning. These examples demonstrate how coupling data collection, modeling, and optimization in this iterative paradigm, while using an exploration-exploitation trade-off in each iteration, can reduce the time and resources for complex optimization tasks such as the one demonstrated here.
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Top Cited PapersOpen AccessAccelerating cell culture media development using Bayesian optimization-based iterative experimental design
Optimizing operational conditions for complex biological systems used in life sciences research and biotechnology is an arduous task. Here, we apply a Bayesian Optimization-based iterative framework for experimental design to accelerate cell culture media development for two applications. First, we show that this approach yields new compositions of media with cytokine supplementation to maintain the viability and distribution of human peripheral blood mononuclear cells in the culture. Second, we apply this framework to optimize the production of three recombinant proteins in cultivations of K.phaffii. We identified conditions with improved outcomes for both applications compared to the initial standard media using 3–30 times fewer experiments than that estimated for other methods such as the standard Design of Experiments. Subsequently, we also demonstrated the extensibility of our approach to efficiently account for additional design factors through transfer learning. These examples demonstrate how coupling data collection, modeling, and optimization in this iterative paradigm, while using an exploration-exploitation trade-off in each iteration, can reduce the time and resources for complex optimization tasks such as the one demonstrated here.